Israel Englander’s Nuvalent NUVL Stock Holding History

Israel Englander’s Portfolio NUVL Stock Details NUVL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-2,500	Closed	-$256K	–	6295
2024 Q3	$256K	Buy	+2,500	New	+$207K	﹤0.01%	5301

Other funds holding NUVL

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

Israel Englander's NUVL Position: Q2 2026 in Review

Israel Englander increased its Nuvalent (NUVL) stake by 2,138% in Q2 2026, buying an estimated $41.5M and bringing the position to 404,192 shares worth $49.9M. The position accounts for 0.02% of the portfolio, ranked #892.

Israel Englander first reported a position in NUVL in Q2 2022 and has held it in 13 quarters since. 287 funds tracked by Wall St. Rank hold NUVL as of Q2 2026.

Israel Englander held 404,192 shares of Nuvalent worth $49.9M as of Q2 2026.
Israel Englander bought 386,135 Nuvalent shares in Q2 2026, an estimated $41.5M.
Nuvalent made up 0.02% of Israel Englander's portfolio in Q2 2026, its #892 holding.
Israel Englander first reported a position in Nuvalent in Q2 2022 and has held it in 13 quarters since.
287 funds tracked by Wall St. Rank held Nuvalent as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.